HC Wainwright reissued their buy rating on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock. Several other brokerages have also recently commented on UNCY. Noble Financial started coverage on Unicycive Therapeutics in a research report on […]
Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 437.76% from the stock’s previous close. A number of […]
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 35,000 shares, a decline of 64.3% from the February 14th total of 98,000 shares. Currently, 0.1% of the company’s stock are sold short. […]
Q3 2023 EPS Estimates for Unicycive Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:UNCY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report)’s stock price shot up 0.8% during mid-day trading on Monday . The stock traded as high as $1.28 and last traded at $1.23. 70,231 shares traded hands during trading, a decline of 97% from the average session volume of 2,732,852 shares. The stock had previously closed at […]